On track to report initial data from Phase 1/2 clinical trial of PM359 for p47phox CGD in 2025 -- -- IND-enabling studies ongoing for PM577 for Wilson's Disease; expect to file IND and/or CTA in ...
CAMBRIDGE, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to ...
Could it also give us better tomatoes, a hybrid woolly mammoth-elephant that could help save Arctic forests, and perhaps even ...
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...
EnPlusOne uses what it calls a “universal enzyme,” one enzyme that can make multiple modifications, which Ahlstedt says is ...
Recent developments in genetic technologies have provided prospective parents with increasing opportunities to influence ...
When the monkeys were single-celled embryos, scientists had used CRISPR editing tools to silence, or “knock out”, a gene that ...
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
Have you ever found yourself in a chaotic Excel workbook, where multiple people are editing the same cells, accidentally overwriting each other’s work, or making unintended changes? It’s ...
Joint injury induces rapid and sustained diversification of resident and infiltrating synovial macrophage phenotypes, underpinning osteoarthritis-associated synovitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback